Wednesday July 17, 2019 15:57

Heathcare Press Release : 08 Feb 2019

BioLineRx Announces Closing of $15.4 Million Underwritten Public Offering of its American Heathcare—08 Feb 19

BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, today announced that it has closed its previously announced underwritten public offering of 28,000,000 American Depositary Shares ("ADSs"),

OneTouch(R) Blood Glucose Monitoring System Accuracy Proven in New Long-Term Heathcare—08 Feb 19

Research demonstrates clinical accuracy of OneTouch Select Plus(R) platform, and demonstrates the value of a continuous and systematic testing program to verify product performance for as long as it has been available to patients New research published